Red cell interactions with amyloid-β1-40 fibrils in a murine model

Neurobiology of Disease

Volumn 19, Issue 1-2, 2005, Pages 28-37

  Ravi, Luke B ^a   Poosala, Suresh ^a   Ahn, Dongchoon ^a   Chrest, Francis J ^c   Spangler, Edward L ^a   Jayakumar, Rajadas ^a,b   Nagababu, Enika ^a   Mohanty, Joy G ^a   Talan, Mark ^a   Ingram, Donald K ^a   Rifkind, Joseph M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^c NONE

Author keywords

Alzheimer's disease; Erythrocytes; Immunohistochemistry; Liver; Murine in vivo study; Spleen; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; HEME;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ERYTHROCYTE; FIBER; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; MALE; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; SPLEEN;

EID: 20244388150     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.11.004     Document Type: Article

References (31)

1. G.J. Bosman, I.G. Bartholomeus, A.J. de Man, P.J. van Kalmthout, and W.J. de Grip Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease Neurobiol. Aging 12 1991 13 18
2. M. Chen, N.C. Inestrosa, G.S. Ross, and H.L. Fernandez Platelets are the primary source of amyloid beta-peptide in human blood Biochem. Biophys. Res. Commun. 213 1995 96 103
3. J.A. Christian, A.H. Rebar, G.D. Boon, and P.S. Low Methodologic considerations for the use of canine in vivo aged biotinylated erythrocytes to study RBC senescence Exp. Hematol. 24 1996 82 88
4. J.C. de la Torre Vascular basis of Alzheimer's pathogenesis Ann. N. Y. Acad. Sci. 977 2002 196 215
5. R.B. DeMattos, K.R. Bales, D.J. Cummins, J.C. Dodart, S.M. Paul, and D.M. Holtzman Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 98 2001 8850 8855
6. L. Dini, M. Ruzittu, E.C. Carla, and L. Falasca Relationship between cellular shape and receptor-mediated endocytosis: an ultrastructural and morphometric study in rat Kupffer cells Liver 18 1998 99 109
7. H. Fukumoto, M. Tennis, J.J. Locascio, B.T. Hyman, J.H. Growdon, and M.C. Irizarry Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels Arch. Neurol. 60 2003 958 964
8. J. Ghiso, E. Matsubara, A. Koudinov, N.H. Choi-Miura, M. Tomita, T. Wisniewski, and B. Frangione The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane attack complex Biochem. J. 293 Pt 1 1993 27 30
9. H.B. Goodall, A.H. Reid, D.J. Findlay, C. Hind, J. Kay, and G. Coghill Irregular distortion of the erythrocytes (acanthocytes, spur cells) in senile dementia Dis. Markers 12 1994 23 41
10. P. Grammas, M. Yamada, and B. Zlokovic The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease J. Alzheimer's Dis. 4 2002 217 223
11. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
12. G. Hoffmann-Fezer, J. Mysliwietz, W. Mortlbauer, H.J. Zeitler, E. Eberle, U. Honle, and S. Thierfelder Biotin labeling as an alternative nonradioactive approach to determination of red cell survival Ann. Hematol. 67 1993 81 87
13. R. Jayakumar, J.W. Kusiak, F.J. Chrest, A.A. Demehin, J. Murali, R.P. Wersto, E. Nagababu, L. Ravi, and J.M. Rifkind Red cell perturbations by amyloid beta-protein Biochim. Biophys. Acta 1622 2003 20 28
14. R.N. Kalaria Small vessel disease and Alzheimer's dementia: pathological considerations Cerebrovasc. Dis. 13 Suppl. 2 2002 48 52
15. J. Kang, H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, K.H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325 1987 733 736
16. A. Koudinov, E. Matsubara, B. Frangione, and J. Ghiso The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma Biochem. Biophys. Res. Commun. 205 1994 1164 1171
17. A.R. Koudinov, T.T. Berezov, A. Kumar, and N.V. Koudinova Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids Clin. Chim. Acta 270 1998 75 84
18. Y.M. Kuo, T.A. Kokjohn, W. Kalback, D. Luehrs, D.R. Galasko, N. Chevallier, E.H. Koo, M.R. Emmerling, and A.E. Roher Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma Biochem. Biophys. Res. Commun. 268 2000 750 756
19. M.A. Lindorfer, C.S. Hahn, P.L. Foley, and R.P. Taylor Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications Immunol. Rev. 183 2001 10 24
20. J.B. Mackic, M.H. Weiss, W. Miao, E. Kirkman, J. Ghiso, M. Calero, J. Bading, B. Frangione, and B.V. Zlokovic Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy J. Neurochem. 70 1998 210 215
21. A.B. Manodori, and F.A. Kuypers Altered red cell turnover in diabetic mice J. Lab. Clin. Med. 140 2002 161 165
22. 2+ homeostasis and cell death J. Neurosci. 15 1995 6239 6249
23. J. McLaurin, A.A. Darabie, and M.R. Morrison Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis Pharmacopsychiatry 36 Suppl. 2 2003 S130 S135
24. A. Nardin, M.A. Lindorfer, and R.P. Taylor How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells? Mol. Immunol. 36 1999 827 835
25. K. Pattanapanyasat, K. Yongvanitchit, P. Tongtawe, K. Tachavanich, W. Wanachiwanawin, S. Fucharoen, and D.S. Walsh Impairment of Plasmodium falciparum growth in thalassemic red blood cells: further evidence by using biotin labeling and flow cytometry Blood 93 1999 3116 3119
26. L.B. Ravi, J.G. Mohanty, F.J. Chrest, R. Jayakumar, E. Nagababu, P.V. Usatyuk, V. Natarajan, and J.M. Rifkind Influence of beta-amyloid fibrils on the interactions between red blood cells and endothelial cells Neurol. Res. 26 2004 579 585
27. J.M. Rifkind, O.O. Abugo, R.R. Peddada, N. Patel, D. Speer, C. Balagopalakrishna, D. Danon, D.K. Ingram, and E.L. Spangler Maze learning impairment is associated with stress hemopoiesis induced by chronic treatment of aged rats with human recombinant erythropoietin Life Sci. 64 1999 237 247
28. M. Shayo, R.N. McLay, A.J. Kastin, and W.A. Banks The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations Life Sci. 60 1997 PL115 PL118
29. T. Suzuki, and G.L. Dale Biotinylated erythrocytes: in vivo survival and in vitro recovery Blood 70 1987 791 795
30. V. Terpstra, and T.J. van Berkel Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice Blood 95 2000 2157 2163
31. Y. Verdier, M. Zarandi, and B. Penke Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease J. Pept. Sci. 10 2004 229 248